Answers are grounded in this paper and cite their sources.
A recent study by Haapaniemi et al (2018) reported that intact p53 signaling hampers CRISPR-based functional genomic screens. Brown et al report good performance of genome-scale screens in TP53 wild-type cells and reiterate best practices for CRISPR screening.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: